𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines

✍ Scribed by Dietmar Thurnher; Maia Bakroeva; Michael Formanek; Birgit Knerer; Johannes Kornfehl


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
166 KB
Volume
23
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Antiproliferative effects in neoplastic cells of different origin have been attributed to non‐steroidal anti‐inflammatory Drugs (NSAIDs) during the past few decades.

Methods

We tested the influence of NSAIDs and hydrocor‐tisone on cell lines derived from head and neck squamous cell cancer (HNSCC) and on normal oral mucosal keratinocytes. Cell numbers were assayed by cell counting, proliferation, telomerase activity with a colorimetric assay, and cell cycle distribution by flow cytometry.

Results

In the neoplastic cell lines indomethacin and ibuprofen caused a dose‐dependent reduction of cell numbers and telomerase activity without altering cell viability and increased the percentage of cells in G0/G1 phase. In normal oral mucosal keratinocytes, only minor effects could be detected in response to NSAIDs and hydrocortisone.

Conclusion

These results demonstrate that NSAIDs have activity against HNSCC cells in vitro and may have clinical applications in combination with other therapeutic regimens. © 2001 John Wiley & Sons, Inc. Head Neck 23: 1049–1055, 2001.


📜 SIMILAR VOLUMES


Bcl-xL inhibits p53- but not apoptin-ind
✍ Remilio A.L. Schoop; Klaas Kooistra; Robert J. Baatenburg de Jong; Mathieu H.M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB 👁 1 views

Nonfunctional p53 and especially upregulation of Bcl-x(L) result in advanced disease and poor prognosis of patients suffering head and neck squamous cell carcinoma (HNSCC). Aberrancies of Bcl-x(L) and/or p53 in HNSCC lead to inability of anticancer drugs to induce apoptosis. Bcl-x(L) and/or mutated

Apoptosis induction and cyclooxygenase-2
✍ Douglas J.E. Elder; Dawn E. Halton; Tracey E. Crew; Christos Paraskeva 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 226 KB 👁 2 views

We determined the effect of the highly selective cyclooxygenase-2 (COX-2) inhibitor NS-398 on proliferation, apoptosis and COX-2 regulation in 3 pre-malignant human colorectal adenoma cell lines (RG/C2, AA/C1, RR/C1) and compared its effect on 3 colorectal carcinoma cell lines (HT29, KS, JW2). COX-2

Constitutive activation of transcription
✍ Frank G. Ondrey; Gang Dong; John Sunwoo; Zhong Chen; Jeffrey S. Wolf; Caren V. C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 1 views

We previously reported that human head and neck squamous cell carcinomas (HNSCCs) express the proinflammatory and pro-angiogenic cytokines interleukin (IL)-1a, IL-6, IL-8, and granulocyte-macrophage colonystimulating factor in vitro and in vivo. The promoter region of the genes encoding these cytoki

Overexpression of interleukin-2 receptor
✍ Deborah J. Kuhn; David M. Smith; Seth Pross; Theresa L. Whiteside; Q. Ping Dou 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Abstract It has been previously demonstrated that human carcinomas express interleukin‐2 receptor (IL‐2R) α, β, and γ chains. The β and γ chains of IL‐2R have intermediate binding affinity for IL‐2 and are responsible for the intracellular signaling cascades after IL‐2 stimulation. IL‐2Rα lacks